Industry Leaders

The companies transforming drug discovery with human-relevant technologies

150+
Active Companies
$15B+
Total Funding Raised
50+
Pharma Partnerships
12
Public Companies
Enterprise Intelligence

Navigate the Ecosystem

Access comprehensive intelligence across technology categories, global regions, investment analysis, and competitive research tools.

Browse by Technology

Organ-on-Chip

45+ MPS platforms including body-on-chip systems

View Directory

AI Drug Discovery

60+ AI/ML platforms transforming discovery

View Directory

Organoid Platforms

35+ organoid & iPSC technology leaders

View Directory

3D Bioprinting

25+ bioprinting & biofabrication companies

View Directory

Tissue Providers

20+ human tissue & biospecimen suppliers

View Directory

Browse by Region

????North America

80+ companies across Boston, Bay Area, Salt Lake City, San Diego & Canadian hubs

Boston Bay Area Salt Lake San Diego

????Europe

50+ companies across UK, Germany, Netherlands, Switzerland & France

UK Germany Netherlands Switzerland

??Asia-Pacific

30+ companies in China, Israel, Japan, South Korea, Australia & India

China Israel Japan S. Korea

Investment Intelligence

Funding Leaders

Top 10 most funded companies, M&A activity, key investors

$15B+ Tracked

Public Companies

NASDAQ, NYSE & international exchange listings

12 Listed

Startups to Watch

Emerging companies with breakthrough potential

2025 Picks

Research Tools

Platform Comparison

Side-by-side comparison tables for organ-on-chip, AI, and organoid platforms

Technology Matrix

Organ coverage, application capabilities, and technology approach analysis

Partnership Network

Strategic alliances, pharma partnerships, and research consortia mapping
Category Leaders

Organ-on-Chip

Emulate

FDA ISTAND-qualified Liver-Chip. 87% sensitivity for DILI prediction. Human Emulation System. Wyss Institute spinout.

$225M Raised

CN Bio

PhysioMimix multi-organ MPS. Liver, gut, and multi-organ platforms for ADME-Tox.

UK-Based

TissUse

HUMIMIC multi-organ chips. German engineering for systemic pharmacology.

Germany

Mimetas

OrganoPlate platform for 3D organ-on-chip models. High-throughput screening capabilities.

Netherlands
Category Leaders

AI Drug Discovery

Recursion Pharmaceuticals

$1B+ AI drug discovery. Acquired Cyclica, Valence. Nvidia partnership. NASDAQ: RXRX.

Public Company

Insilico Medicine

Chemistry42, Biology42 platforms. First AI-designed drug in clinical trials.

$400M+ Raised

Exscientia

AI-driven drug design with multiple pharma partnerships. Multiple clinical-stage assets.

Public Company

Schr—dinger

Physics-based molecular modeling platform. Powers drug discovery at major pharma.

NASDAQ: SDGR
Category Leaders

Organoid Platforms

Organovo

3D bioprinting pioneer now focused on therapeutics. ExVive liver and kidney models.

OTC Listed

HUB Organoids

Netherlands biobank. Acquired by Merck Dec 2024. Hans Clevers founded.

Netherlands

Crown Bioscience

Patient-derived tumor organoids for oncology drug development. Global CRO services.

JSR Acquisition

StemoniX

iPSC-derived screening platform. microBrain and microHeart models for neuroscience and cardiology.

Minnesota
Deep Dive

Company Profiles

Detailed profiles of leading human simulation technology companies

Emulate

Organs-on-Chips platform

TissUse

Multi-organ chips

CN Bio

PhysioMimix platform

MIMETAS

OrganoPlate technology

Hesperos

Human-on-a-Chip

InSphero

3D microtissues

Organovo

3D bioprinting

HUB Organoids

Adult stem cell organoids

Crown Bioscience

Tumor organoids CRO

Recursion

AI drug discovery

Insilico Medicine

AI-powered platforms

Quris-AI

Bio-AI clinical prediction

Altis Biosystems

RepliGut platform

AxoSim

Nerve-on-a-chip

Nortis

Kidney & liver chips

Kirkstall

Quasi Vivo systems

MatTek

EpiDerm tissue models

EpiSkin

L'Oréal skin models

BioIVT

Human biological products
View All Companies

Track Market Growth

Explore market intelligence and growth projections for human-relevant medicine technologies.

View Market Data